144 related articles for article (PubMed ID: 33807406)
1. Upregulated Angiogenesis Is Incompetent to Rescue Dilated Cardiomyopathy Phenotype in Mice.
Arif M; Alam P; Ahmed RP; Pandey R; Faridi HM; Sadayappan S
Cells; 2021 Mar; 10(4):. PubMed ID: 33807406
[TBL] [Abstract][Full Text] [Related]
2. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
[TBL] [Abstract][Full Text] [Related]
3. Early sensitization of myofilaments to Ca2+ prevents genetically linked dilated cardiomyopathy in mice.
Alves ML; Warren CM; Simon JN; Gaffin RD; Montminy EM; Wieczorek DF; Solaro RJ; Wolska BM
Cardiovasc Res; 2017 Jul; 113(8):915-925. PubMed ID: 28379313
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
[TBL] [Abstract][Full Text] [Related]
7. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
[TBL] [Abstract][Full Text] [Related]
8. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.
Ahmad F; Banerjee SK; Lage ML; Huang XN; Smith SH; Saba S; Rager J; Conner DA; Janczewski AM; Tobita K; Tinney JP; Moskowitz IP; Perez-Atayde AR; Keller BB; Mathier MA; Shroff SG; Seidman CE; Seidman JG
PLoS One; 2008 Jul; 3(7):e2642. PubMed ID: 18612386
[TBL] [Abstract][Full Text] [Related]
9. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
Lakdawala NK; Dellefave L; Redwood CS; Sparks E; Cirino AL; Depalma S; Colan SD; Funke B; Zimmerman RS; Robinson P; Watkins H; Seidman CE; Seidman JG; McNally EM; Ho CY
J Am Coll Cardiol; 2010 Jan; 55(4):320-9. PubMed ID: 20117437
[TBL] [Abstract][Full Text] [Related]
10. Cardiac vagal control in a knock-in mouse model of dilated cardiomyopathy with a troponin mutation.
Zhan DY; Du CK; Akiyama T; Morimoto S; Shimizu S; Kawada T; Shirai M; Pearson JT
Auton Neurosci; 2017 Jul; 205():33-40. PubMed ID: 28344023
[TBL] [Abstract][Full Text] [Related]
11. Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation.
Lynch TL; Ismahil MA; Jegga AG; Zilliox MJ; Troidl C; Prabhu SD; Sadayappan S
J Mol Cell Cardiol; 2017 Jan; 102():83-93. PubMed ID: 27955979
[TBL] [Abstract][Full Text] [Related]
12. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
Mirza M; Marston S; Willott R; Ashley C; Mogensen J; McKenna W; Robinson P; Redwood C; Watkins H
J Biol Chem; 2005 Aug; 280(31):28498-506. PubMed ID: 15923195
[TBL] [Abstract][Full Text] [Related]
13. Troponin T amino acid mutation (ΔK210) knock-in mice as a neonatal dilated cardiomyopathy model.
Tanihata J; Fujii T; Baba S; Fujimoto Y; Morimoto S; Minamisawa S
Pediatr Res; 2021 Mar; 89(4):846-857. PubMed ID: 32563186
[TBL] [Abstract][Full Text] [Related]
14. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
15. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological and biochemical characterisation of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy.
Hajjar RJ; Liao R; Young JB; Fuleihan F; Glass MG; Gwathmey JK
Cardiovasc Res; 1993 Dec; 27(12):2212-21. PubMed ID: 8313431
[TBL] [Abstract][Full Text] [Related]
17. Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.
Giam B; Chu PY; Kuruppu S; Smith AI; Horlock D; Murali A; Kiriazis H; Du XJ; Kaye DM; Rajapakse NW
Exp Physiol; 2018 Dec; 103(12):1593-1602. PubMed ID: 30311699
[TBL] [Abstract][Full Text] [Related]
18. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
[TBL] [Abstract][Full Text] [Related]
19. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
[TBL] [Abstract][Full Text] [Related]
20. No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.
Cooley N; Ouyang K; McMullen JR; Kiriazis H; Sheikh F; Wu W; Mu Y; Du XJ; Chen J; Woodcock EA
Circ Heart Fail; 2013 Mar; 6(2):318-25. PubMed ID: 23258573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
